Zhimeng Biopharma
PrivateLast Round
Series B
Nov 8, 2021
Total Funding Raised
$98M
Company Overview
Zhimeng Biopharma is a biopharmaceutical company that develops innovative small-molecule therapeutics for the treatment of chronic hepatitis B and neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zhimeng Biopharma Comparables
Compare Zhimeng Biopharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeuShen Therapeutics | 78% | |
| Shanghai Hepu Pharmaceutical Co., Ltd. | 74% | |
| Brii Biosciences | 74% | |
Zhimeng Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 8, 2021 | ||||
| Series A | Nov 6, 2020 | ||||
| Pre Seed | Nov 11, 2019 |
Zhimeng Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Photon Fund | Series A |
| SDIC Unity Capital | Series A |
| 中南创投基金 | Series A |
| Shenzhen Dachen Caizhi Venture Capital Management | Series B |
| Trinity Innovation Fund | Series A |
| Advantech Capital | Series B |
| Lake Capital | Series A, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 5, 2026
Monthly visitors increased 112% MoM.
Zhimeng Biopharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Zhimeng Biopharma's valuation, stock price, and market status.